Cas 1448426-96-7,1-(4-(6-(trifluoromethyl)-3,4-dihydroquinolin-1(2H)-ylsulfonyl)phenyl)pyrrolidin-2-one

1448426-96-7

Post Buying Request

Basic information

Product Name: 1-(4-(6-(trifluoromethyl)-3,4-dihydroquinolin-1(2H)-ylsulfonyl)phenyl)pyrrolidin-2-one
Synonyms: 1-(4-(6-(trifluoromethyl)-3,4-dihydroquinolin-1(2H)-ylsulfonyl)phenyl)pyrrolidin-2-one
CAS NO:1448426-96-7
Molecular Formula:
Molecular Weight: 424.444
EINECS: N/A
Product Categories: N/A
Mol File: 1448426-96-7.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(4-(6-(trifluoromethyl)-3,4-dihydroquinolin-1(2H)-ylsulfonyl)phenyl)pyrrolidin-2-one(CAS DataBase Reference)
NIST Chemistry Reference: 1-(4-(6-(trifluoromethyl)-3,4-dihydroquinolin-1(2H)-ylsulfonyl)phenyl)pyrrolidin-2-one(1448426-96-7)
EPA Substance Registry System: 1-(4-(6-(trifluoromethyl)-3,4-dihydroquinolin-1(2H)-ylsulfonyl)phenyl)pyrrolidin-2-one(1448426-96-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1448426-96-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1448426-96-7 Suppliers

Recommended suppliersmore

1448426-96-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1448426-96-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,8,4,2 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1448426-96:
(9*1)+(8*4)+(7*4)+(6*8)+(5*4)+(4*2)+(3*6)+(2*9)+(1*6)=187
187 % 10 = 7
So 1448426-96-7 is a valid CAS Registry Number.

1448426-96-7Upstream product

1448426-96-7Downstream Products

1448426-96-7Relevant articles and documents

Novel tertiary sulfonamides as potent anti-cancer agents

Okolotowicz, Karl J.,Dwyer, Mary,Ryan, Daniel,Cheng, Jiongjia,Cashman, Emily A.,Moore, Stephanie,Mercola, Mark,Cashman, John R.

, p. 4441 - 4451 (2018/08/03)

For adult women in the United States, breast cancer is the most prevalent form of cancer. Compounds that target dysregulated signal transduction can be efficacious anti-cancer therapies. A prominent signaling pathway frequently dysregulated in breast canc

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1448426-96-7